A. Didier

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis

A. Didier, Hans‐Jørgen Malling, Margitta Worm et al. · Journal of Allergy and Clinical Immunology · 2007 · 485 citations

Asthma, Allergy, Optimal Dose +8

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

[Association of T lymphoma localized at the sacrum and pulmonary sarcoidosis].

M. Laroche, F. Huguet, A. Didier et al. · PubMed · 1992 · 280 citations

ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society

Gérard Huchon, M. Woodhead, G Gialdroni-Grassi et al. · European Respiratory Journal · 1998 · 227 citations · Full text

Respiratory Diseases, Healthcare-associated Infection, Clinical Epidemiology +9

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 227 citations